Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
192.2 USD | -1.53% | -4.66% | -25.74% |
03:58pm | UBS Adjusts Biogen's Price Target to $214 From $250, Maintains Neutral Rating | MT |
01:26pm | Wedbush Cuts Biogen's Price Target to $213 From $245 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-25.74% | 28.37B | |
-4.89% | 85.08B | |
+2.11% | 40.14B | |
+51.96% | 24.07B | |
-6.17% | 17.24B | |
-31.09% | 13.85B | |
-6.58% | 12.29B | |
-16.04% | 11.95B | |
-4.19% | 8.02B | |
+7.08% | 7.73B |
- Stock Market
- Equities
- BIIB Stock
- News Biogen Inc.
- Biogen : Truist Securities Adjusts Biogen's Price Target to Street-High $647 From $458; Reiterates Buy Rating